Prevalence of Thyroid Peroxidase and Thyroglobulin Autoantibodies in the Swedish Population

Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab), thyroglobulin (TGab), or both.The present study aimed to develop a novel radiobinding assay (RBA) for TPOab and to determine the prevalence of TPOab...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and clinical endocrinology & diabetes Vol. 131; no. 9; p. 456
Main Authors: Bergemann, Neele, Jonsdottir, Berglind, Nilsson, Anna-Lena, Lantz, Mikael, Lind, Alexander
Format: Journal Article
Language:English
Published: Germany 01.09.2023
ISSN:1439-3646, 1439-3646
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab), thyroglobulin (TGab), or both.The present study aimed to develop a novel radiobinding assay (RBA) for TPOab and to determine the prevalence of TPOab and TGab in the Swedish population.Patient samples from 27 newly diagnosed Graves' disease patients in longitudinal follow-up and 124 AITD autoantibody-positive children in prospective follow-up for increased risk of type 1 diabetes were included to validate the novel RBA for TPO. The results of RBA were compared with those obtained by commercial radioimmunoassay (RIA) and electrochemiluminescence (ECL). Furthermore, 476 serum samples from adult blood donors and 297 from 13-year-old school children were analyzed for the presence of TPOab and TGab.Receiver operating characteristics analysis for the novel TPOab resulted in an area under curve (AUC) value of 0.82 (p<0.0001), a sensitivity of 77.8%, and a specificity of 91.9% in adult blood donors, and an AUC value of 0.70 (p<0.0001), a sensitivity of 53.2% and a specificity of 95.3% in the 13-year-old school children, respectively. TPOab levels in RBA correlated with both ECL (r=0.8950, p<0.0001) and RIA (r=0.9295, p<0.0001). The prevalence of TPOab and TGab was 6.3% and 7.6% in adult blood donors and 2.9 and 3.7% in 13-year-old school children.In conclusion, a novel RBA for the determination of TPOab was developed and validated with current methodologies. This study also reports an increasing prevalence of thyroid autoantibodies from adolescence to adulthood.
AbstractList Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab), thyroglobulin (TGab), or both.The present study aimed to develop a novel radiobinding assay (RBA) for TPOab and to determine the prevalence of TPOab and TGab in the Swedish population.Patient samples from 27 newly diagnosed Graves' disease patients in longitudinal follow-up and 124 AITD autoantibody-positive children in prospective follow-up for increased risk of type 1 diabetes were included to validate the novel RBA for TPO. The results of RBA were compared with those obtained by commercial radioimmunoassay (RIA) and electrochemiluminescence (ECL). Furthermore, 476 serum samples from adult blood donors and 297 from 13-year-old school children were analyzed for the presence of TPOab and TGab.Receiver operating characteristics analysis for the novel TPOab resulted in an area under curve (AUC) value of 0.82 (p<0.0001), a sensitivity of 77.8%, and a specificity of 91.9% in adult blood donors, and an AUC value of 0.70 (p<0.0001), a sensitivity of 53.2% and a specificity of 95.3% in the 13-year-old school children, respectively. TPOab levels in RBA correlated with both ECL (r=0.8950, p<0.0001) and RIA (r=0.9295, p<0.0001). The prevalence of TPOab and TGab was 6.3% and 7.6% in adult blood donors and 2.9 and 3.7% in 13-year-old school children.In conclusion, a novel RBA for the determination of TPOab was developed and validated with current methodologies. This study also reports an increasing prevalence of thyroid autoantibodies from adolescence to adulthood.Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab), thyroglobulin (TGab), or both.The present study aimed to develop a novel radiobinding assay (RBA) for TPOab and to determine the prevalence of TPOab and TGab in the Swedish population.Patient samples from 27 newly diagnosed Graves' disease patients in longitudinal follow-up and 124 AITD autoantibody-positive children in prospective follow-up for increased risk of type 1 diabetes were included to validate the novel RBA for TPO. The results of RBA were compared with those obtained by commercial radioimmunoassay (RIA) and electrochemiluminescence (ECL). Furthermore, 476 serum samples from adult blood donors and 297 from 13-year-old school children were analyzed for the presence of TPOab and TGab.Receiver operating characteristics analysis for the novel TPOab resulted in an area under curve (AUC) value of 0.82 (p<0.0001), a sensitivity of 77.8%, and a specificity of 91.9% in adult blood donors, and an AUC value of 0.70 (p<0.0001), a sensitivity of 53.2% and a specificity of 95.3% in the 13-year-old school children, respectively. TPOab levels in RBA correlated with both ECL (r=0.8950, p<0.0001) and RIA (r=0.9295, p<0.0001). The prevalence of TPOab and TGab was 6.3% and 7.6% in adult blood donors and 2.9 and 3.7% in 13-year-old school children.In conclusion, a novel RBA for the determination of TPOab was developed and validated with current methodologies. This study also reports an increasing prevalence of thyroid autoantibodies from adolescence to adulthood.
Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab), thyroglobulin (TGab), or both.The present study aimed to develop a novel radiobinding assay (RBA) for TPOab and to determine the prevalence of TPOab and TGab in the Swedish population.Patient samples from 27 newly diagnosed Graves' disease patients in longitudinal follow-up and 124 AITD autoantibody-positive children in prospective follow-up for increased risk of type 1 diabetes were included to validate the novel RBA for TPO. The results of RBA were compared with those obtained by commercial radioimmunoassay (RIA) and electrochemiluminescence (ECL). Furthermore, 476 serum samples from adult blood donors and 297 from 13-year-old school children were analyzed for the presence of TPOab and TGab.Receiver operating characteristics analysis for the novel TPOab resulted in an area under curve (AUC) value of 0.82 (p<0.0001), a sensitivity of 77.8%, and a specificity of 91.9% in adult blood donors, and an AUC value of 0.70 (p<0.0001), a sensitivity of 53.2% and a specificity of 95.3% in the 13-year-old school children, respectively. TPOab levels in RBA correlated with both ECL (r=0.8950, p<0.0001) and RIA (r=0.9295, p<0.0001). The prevalence of TPOab and TGab was 6.3% and 7.6% in adult blood donors and 2.9 and 3.7% in 13-year-old school children.In conclusion, a novel RBA for the determination of TPOab was developed and validated with current methodologies. This study also reports an increasing prevalence of thyroid autoantibodies from adolescence to adulthood.
Author Bergemann, Neele
Jonsdottir, Berglind
Lind, Alexander
Nilsson, Anna-Lena
Lantz, Mikael
Author_xml – sequence: 1
  givenname: Neele
  surname: Bergemann
  fullname: Bergemann, Neele
  organization: Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
– sequence: 2
  givenname: Berglind
  surname: Jonsdottir
  fullname: Jonsdottir, Berglind
  organization: Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
– sequence: 3
  givenname: Anna-Lena
  surname: Nilsson
  fullname: Nilsson, Anna-Lena
  organization: Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
– sequence: 4
  givenname: Mikael
  surname: Lantz
  fullname: Lantz, Mikael
  organization: Department of Endocrinology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö and Lund, Sweden
– sequence: 5
  givenname: Alexander
  surname: Lind
  fullname: Lind, Alexander
  organization: Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37380031$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LAzEYhINU7IeevEuOXlbzJttscizFLyhYsJ48LNnNGxvZJnWzq_bfW2gFTzPzMMxhxmQQYkBCLoHdAJtOb03GmZaZljmckBHkQmdC5nLwzw_JOKUPxiDXoM_IUBRCMSZgRN6WLX6ZBkONNDq6Wu_a6C1dYht_vDUJqQn2gN-bWPWND3TWd9GEzlfRekx0T7o10pdvtD6t6TJu-8Z0PoZzcupMk_DiqBPyen-3mj9mi-eHp_lskdVCQpfVU8ELnmNhVeUsV07sk1MFKnSSVcyBBlBK1hVHAQyEAKtcVStUGmsj-IRcH3a3bfzsMXXlxqcam8YEjH0quRLAtWQK9tWrY7WvNmjLbes3pt2Vf4fwX0qSZBU
CitedBy_id crossref_primary_10_3389_fped_2024_1386513
ContentType Journal Article
Copyright The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Copyright_xml – notice: The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
DBID NPM
7X8
DOI 10.1055/a-2096-9641
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1439-3646
ExternalDocumentID 37380031
Genre Journal Article
GroupedDBID ---
0R~
123
4.4
5RE
5~~
AAIWL
ABJNI
ABZLV
ACGFS
ACKTL
AENEX
AEVEF
AHRAW
AHRSK
AIVKU
AJGCD
AKJTW
ALMA_UNASSIGNED_HOLDINGS
CS3
DU5
EXEOM
H13
IY8
N9A
NPM
O9-
P2P
Q3R
QTC
RTC
7X8
ACNUY
AGCGI
ID FETCH-LOGICAL-c361t-c532724e7d8bfd28f3724f87e8ef60b0f1911886cb2e3101331d8fbc8e89eca32
IEDL.DBID 7X8
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001021168700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1439-3646
IngestDate Fri Jul 11 16:21:56 EDT 2025
Thu Jan 02 22:51:06 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c361t-c532724e7d8bfd28f3724f87e8ef60b0f1911886cb2e3101331d8fbc8e89eca32
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-2096-9641.pdf
PMID 37380031
PQID 2831296081
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2831296081
pubmed_primary_37380031
PublicationCentury 2000
PublicationDate 2023-09-01
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Experimental and clinical endocrinology & diabetes
PublicationTitleAlternate Exp Clin Endocrinol Diabetes
PublicationYear 2023
SSID ssj0014919
Score 2.370875
Snippet Autoimmune thyroid disease (AITD) may be detected prior to clinical symptoms through the presence of autoantibodies against thyroid peroxidase (TPOab),...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 456
Title Prevalence of Thyroid Peroxidase and Thyroglobulin Autoantibodies in the Swedish Population
URI https://www.ncbi.nlm.nih.gov/pubmed/37380031
https://www.proquest.com/docview/2831296081
Volume 131
WOSCitedRecordID wos001021168700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7UinhxaV3qxgjibWiWyWRykiIWD7YErFDwECaz0BxMahe1_943SWpPguAlkIFAmHnz3ve27yF0o5gRHPxkYmwJFVWpIlyLgCjqSM6VCh1dUuY_hYMBH42iuA64zeqyypVOLBW1KqSNkXfADIJpYmDB7ibvxE6NstnVeoTGJmr4AGWsVIejdRaBRuVgD4AEEfEZZXV_nhMEHQHiETESMer-ji1LG9Pb_-_fHaC9Gl3ibiUOh2hD503U6ubgWb8t8S0u6z3LQHoT7fTrtHoLvVoiJ1G2H-HC4OF4OS0yhWM9Lb4yBXYOi1xVy5ZAxBav4-5iXsCpZGlh6xAxrACUxM-fts93jOOfuWBH6KX3MLx_JPXUBSJ95s6JDHwv9KgOFU-N8rjx4c3wUHNtmJM6Bjw8l3MmU08DNgQf11XcpJJrHmkpfO8YbeVFrk8RluAuhalvQsAIVFI_dYVHhSUZ9CggHdNG16vdTECqbapC5LpYzJL1frbRSXUkyaSi30gsF5PVRWd_-Poc7dr58FVR2AVqGLjT-hJty495NpteleICz0Hc_wb-Yspk
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Thyroid+Peroxidase+and+Thyroglobulin+Autoantibodies+in+the+Swedish+Population&rft.jtitle=Experimental+and+clinical+endocrinology+%26+diabetes&rft.au=Bergemann%2C+Neele&rft.au=Jonsdottir%2C+Berglind&rft.au=Nilsson%2C+Anna-Lena&rft.au=Lantz%2C+Mikael&rft.date=2023-09-01&rft.issn=1439-3646&rft.eissn=1439-3646&rft.volume=131&rft.issue=9&rft.spage=456&rft_id=info:doi/10.1055%2Fa-2096-9641&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-3646&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-3646&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-3646&client=summon